Effects of passive antibody in bee venom anaphylaxis.
Twelve patients allergic to honeybees were challenged by injections of bee venom; five responded systemically to the venom, with symptoms ranging from angioedema to respiratory distress. These patients were given intramuscular or intravenous infusions of gamma-globulin obtained from the plasma of hyperimmune beekeepers who had high levels of antibody to an allergen (phospholipase A) in the venom. Post-infusion, all five patients tolerated 1.5 to 5 times the venom dose that previously elicited adverse reactions. The quantity of passive IgG antibody infused did not impair the patient's own immune response to venom. These results represent the best available evidence for a direct role for IgG blocking antibodies in clinical protection against anaphylaxis occurring as a result of parenteral antigenic challenge as may be observed in penicillin and insect hypersensitivity.
D000293:Adolescent; D000328:Adult; D000707:Anaphylaxis / Q000276:immunology / Q000517:prevention & control*; D000906:Antibodies / Q000032:analysis; D001514:Bee Venoms / Q000276:immunology*; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010740:Phospholipases / Q000276:immunology; D005719:gamma-Globulins / Q000008:administration & dosage* / Q000627:therapeutic use
D000906:Antibodies; D001514:Bee Venoms; D007074:Immunoglobulin G; D005719:gamma-Globulins; D007073:Immunoglobulin E; D010740:Phospholipases